Assignee
DIFFUSION PHARMACEUTICALS LLC
US·11 granted patents·10 pending applications·72 citations·filing 2003–2024
Top patents by PatentIndex Score
21 records- 0191US8017653B2Bipolar trans carotenoid salts and their usesDIFFUSION PHARMACEUTICALS LLC·Filed 2011·Granted Sep 13, 2011·11 cites·4 claims
- 0289US8030350B2Trans carotenoids, their synthesis, formulation and usesDIFFUSION PHARMACEUTICALS LLC·Filed 2006·Granted Oct 4, 2011·14 cites·61 claims
- 0388US7919527B2Bipolar trans carotenoid salts and their usesDIFFUSION PHARMACEUTICALS LLC·Filed 2010·Granted Apr 5, 2011·8 cites·27 claims
- 0487US9950067B2Trans carotenoids, their synthesis, formulation and usesDIFFUSION PHARMACEUTICALS LLC·Filed 2016·Granted Apr 24, 2018·6 cites·31 claims
- 0585US10016384B2Oral formulations of bipolar trans carotenoidsDIFFUSION PHARMACEUTICALS LLC·Filed 2015·Granted Jul 10, 2018·4 cites·13 claims
- 0685US7759506B2Bipolar trans carotenoid salts and their usesDIFFUSION PHARMACEUTICALS LLC·Filed 2003·Granted Jul 20, 2010·15 cites·11 claims
- 0783US7351844B2Bipolar trans carotenoid salts and their usesDIFFUSION PHARMACEUTICALS LLC·Filed 2003·Granted Apr 1, 2008·12 cites·16 claims
- 0881US11185523B2Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancerDIFFUSION PHARMACEUTICALS LLC·Filed 2017·Granted Nov 30, 2021·1 cites·33 claims
- 0978US2023346733A1Oral formulations of bipolar trans carotenoidsDIFFUSION PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1077US11147859B2Diffusion enhancing compounds and their use alone or with thrombolyticsDIFFUSION PHARMACEUTICALS LLC·Filed 2018·Granted Oct 19, 2021·1 cites·21 claims
- 1175US2022387589A1Trans carotenoids, their synthesis, formulation and usesDIFFUSION PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1271US11278621B2Trans carotenoids, their synthesis, formulation and usesDIFFUSION PHARMACEUTICALS LLC·Filed 2018·Granted Mar 22, 2022·0 cites·29 claims
- 1367US2022265592A1Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancerDIFFUSION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1463US11491129B2Oral formulations of bipolar trans carotenoidsDIFFUSION PHARMACEUTICALS LLC·Filed 2018·Granted Nov 8, 2022·0 cites·20 claims
- 1561US2007161610A1Bipolar trans carotenoid salts and their usesDIFFUSION PHARMACEUTICALS LLC·Filed 2007·Application pending·0 cites
- 1659US2024300882A1Crystalline forms of a diffusion enhancing compoundDIFFUSION PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1759US2024316000A1Methods of treatmentDIFFUSION PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 1858US2014051759A1Bipolar trans carotenoid salts and their usesDIFFUSION PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 1954US2023181509A1The use of diffusion enhancing compounds for treatment of viral and bacterial induced respiratory diseaseDIFFUSION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2049US2013018014A1New class of therapeutics that enhance small molecule diffusionDIFFUSION PHARMACEUTICALS LLC·Filed 2012·Application pending·0 cites
- 2145US2021244698A1Diffusion enhancing compounds and their use with thrombectomy and embolectomy and other vascular disease proceduresDIFFUSION PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →